Webinar 1: Progression. Now What? Necessary Testing, Common Mechanisms of EGFR-Dependent Resistance, and Possible Treatment Strategies
Guests: Joshua Bauml, MD and Melina Marmarelis, MD, PhD; University of Pennsylvania, Philadelphia, PA
Webinar series highlighting experts in the field of EGFR lung cancer. We'd like to thank Blueprint Medicine for sponsoring the webinar series on Progression and Resistance for the EGFR Resisters community. Also, thank you to CEC Oncology for your assistance with the coordination and production.
Guests: Joshua Bauml, MD and Melina Marmarelis, MD, PhD; University of Pennsylvania, Philadelphia, PA
Guests: Zofia Piotrowska, MD and Catherine Meador, MD, PhD; Mass General, Boston
Guests: Helena Yu, MD and Joseph Chan, MD, PhD; Memorial Sloan Kettering Cancer Center, New York City
An educational overview for EGFR+ patients and their caregivers and how we can help.
Dr. Nieva discusses patient selection for clinical trials and the Epidemiology of Young Lung Cancer trial that he is leading with GO2 Foundation/ALCMI.
We'd like to thank Eli Lilly for supporting the development of these fact sheets and Breath of Hope Kentucky for partnering with us in their creation.